ストックスクリーナーアプリを入手
39.51
4.28%
1.62
Rigel Pharmaceuticals (RIGL) 最新ニュース
What are Rigel Pharmaceuticals Inc.’s recent SEC filings showingMarket Growth Review & Weekly Stock Breakout Alerts - newsimpact.co.kr
Published on: 2025-08-15 05:51:08 - sundaytimes.kr
Rigel Pharmaceuticals Inc. Recovery Linked to Earnings SurprisePortfolio Update Summary & Free Growth Oriented Trading Recommendations - classian.co.kr
Rigel Pharmaceuticals: Q2 Earnings Fuel A Potential Breakout - Seeking Alpha
Rigel Pharmaceuticals (RIGL) up more than 100% since Jul 18 - AInvest
Rigel Pharmaceuticals' Earnings Mask Underlying Cash Flow Concerns - AInvest
Rigel Pharmaceuticals' (NASDAQ:RIGL) Earnings Are Of Questionable Quality - Yahoo Finance
H.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL), Sets a $57 PT - Insider Monkey
RIPK1 Inhibitor Pipeline Outlook Report 2025: Key 10+ Companies and Breakthrough Therapies Shaping the Future Landscape - The Globe and Mail
Best Momentum Stock to Buy for August 8th - MSN
Rigel targets up to $280M 2025 revenue as IRA boosts sales and pipeline advances - MSN
Is Rigel Pharmaceuticals Inc. a candidate for recovery playPredictable Entry Strategy With Technical Backing - Newser
Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy? - Yahoo Finance
Top 5 Stocks with Strong Price Performance to Buy Now - AInvest
5 Best Stocks With Relative Price Strength to Buy Right Now - sg.finance.yahoo.com
Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Yahoo Finance
New Strong Buy Stocks for August 8th - TradingView
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2025 Earnings Call Transcript - Insider Monkey
Rigel Pharmaceuticals Flips To A Profit On Rising Sales - Finimize
Jefferies Reaffirms Their Hold Rating on Rigel (RIGL) - The Globe and Mail
Rigel Pharmaceuticals (RIGL) Just Flashed Golden Cross Signal: Do You Buy? - Yahoo Finance
Rigel Pharmaceuticals, Inc. (RIGL) Hits Fresh High: Is There Still Room to Run? - Yahoo Finance
Citi Analysts Maintain Buy Rating on Rigel with $67 Price Target - AInvest
Rigel Pharmaceuticals' Shares Hit New High: Is There Room to Run? - AInvest
Rigel Pharmaceuticals (RIGL) Q2 Earnings and Revenues Surpass Estimates - MSN
Rigel Pharmaceuticals’ Earnings Call Highlights Robust Growth - TipRanks
H.C. Wainwright Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Maintains Target Price $57 - 富途牛牛
Citi Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $67 - 富途牛牛
Rigel Pharmaceuticals (NASDAQ:RIGL) Shareholder Returns Have Been Solid, Earning 160% in 1 Year - 富途牛牛
Cantor Fitzgerald Raises Price Target for RIGL to $32.00, Mainta - GuruFocus
Rigel Pharmaceuticals shares surge 16.67% intraday after strong Q2 earnings and revenue guidance. - AInvest
Rigel Pharmaceuticals: Cantor Fitzgerald Maintains Neutral, PT Raised to $32 from $23. - AInvest
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Held Back By Insufficient Growth Even After Shares Climb 28% - simplywall.st
Rigel (RIGL) Q2 Revenue Jumps 176% - The Globe and Mail
Rigel (RIGL) Q2 Revenue Jumps 176% - The Motley Fool
Jefferies raises Rigel Pharmaceuticals stock price target on strong sales By Investing.com - Investing.com Nigeria
Jefferies raises Rigel Pharmaceuticals stock price target on strong sales - Investing.com
RIGL files S-8 to register 825,000 shares for employee equity plans | RIGL SEC FilingForm S-8 - Stock Titan
Rigel Pharmaceuticals Q2 2025 Earnings Call Transcript - MarketBeat
Rigel: Q2 Earnings Snapshot - New Haven Register
TR | OpenAI4o Maintains Rigel Pharmaceuticals(RIGL.US) With Buy Rating, Raises Target Price to $25 - 富途牛牛
Rigel Pharmaceuticals Exceeds Q2 2025 Revenue Guidance with 76% YoY Increase - AInvest
Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ... - Yahoo Finance
Rigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlight - GuruFocus
Rigel Pharmaceuticals Reports Strong Q2 2025 Results - TipRanks
Rigel Pharmaceuticals' Q2 2025: Unpacking Contradictions in Tavalisse Growth and GAVRETO Sales Dynamics - AInvest
Rigel Pharmaceuticals Sets Ambitious 2025 Revenue Target of $280M as IRA Boosts Sales and Pipeline Advances - AInvest
Rigel Pharmaceuticals, Inc. 2025 Q2ResultsEarnings Call Presentation (NASDAQ:RIGL) - Seeking Alpha
Rigel Pharmaceuticals (RIGL): A High-Growth Biotech Play with a Self-Funding Pipeline and Expanding Global Reach - AInvest
Transcript : Rigel Pharmaceuticals, Inc., Q2 2025 Earnings Call, Aug 05, 2025 - MarketScreener
Earnings call transcript: Rigel Pharmaceuticals Q2 2025 boosts guidance, stock rises - Investing.com India
Earnings call transcript: Rigel Pharmaceuticals Q2 2025 boosts guidance, stock rises By Investing.com - Investing.com South Africa
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):